Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK materials technology co CSMA sets sights on US:

This article was originally published in Clinica

Executive Summary

UK materials analysis specialist CSMA has announced plans to expand into North America, initially by setting up a surface characterisation service in the US, by the end of 2005. CSMA's plans are bolstered by the addition of a new time-of-flight secondary ion mass spectrometer, in which it has invested £500,000 ($934,000). Cardiovascular stents and orthopaedic implants are among the technologies that the company has helped to develop through its surface characterisation services to manufacturers. The technology has also been used to detect proteins on surgical instruments. CSMA and its parent company CERAM (British Ceramic Research) are based in Penkhull, Stoke-on-Trent (Staffordshire).





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts